Delivery Order SPE2DB22D2206-SPE2DB24FFQ79
Award Date 2/14/24
Potential Completion Date 2/15/24
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Deferasirox 500 mg tablets for suspension. The contract has a ceiling value of $2,455.30 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under a larger...
- This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,991.52 to AmerisourceBergen Drug Corp for Deferasirox 500 mg tablets for suspension (30-count units) on September 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and is scheduled for completion by September 25, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,882.12 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count) on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price, non-set-aside contract was issued as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling through December 2026....
- This is a firm fixed price delivery order for 360mg Deferasirox tablets awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $52,303.36 contract has a completion date of January 18, 2024 and was awarded on January 17, 2024. There was no set-aside designation used for this award. As a prime contractor, AmerisourceBergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp in the amount of $25,052.94 for the supply of Deferiprone 1,000 mg tablets. The contract has a firm fixed price and provides for the delivery of this pharmaceutical product through June 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, supports the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, with a ceiling value of $34,899.12, is for the provision of Deferiprone 500 mg tablets to support military treatment programs and facilities. The contract is a firm fixed price delivery order with an ultimate completion date of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,063.08, is for the delivery of Deferiprone 1,000 mg tablets to support military healthcare programs. The contract is a firm-fixed price type, with an ultimate completion date of January 18, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- The Defense Logistics Agency awarded a delivery order valued at $46,261.42 to AmerisourceBergen Drug Corp for 30-tablet bottles of Jadenu 360 mg on December 10, 2025, with a completion date of December 11, 2025. The award was competitively procured without set-aside designation and is structured as a firm fixed-price delivery order. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...